SCHEMBL18397355

SCHEMBL18397355

COc1ccc(C(=O)/C=C/c2cc(Br)cc(OC)c2O)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.53
MAOB P27338 2/20 0.53
ERN1 O75460 2/20 0.49
DPP4 P27487 4/20 0.48
TNFRSF1A P19438 1/20 0.48
PTPN1 P18031 3/20 0.47
ABCG2 Q9UNQ0 2/20 0.47
MEN1 O00255 1/20 0.47
MITF O75030 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
PAX8 Q06710 1/20 0.47
ATM Q13315 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CAPN1 P07384 1/20 0.46
SNCA P37840 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18397357 1.00 MAOA (0.53) MAOAMAOBERN1DPP4TNFRSF1A
SCHEMBL18397026 0.83 DPP4 (0.66) MAOAMAOBDPP4TNFRSF1APTPN1
SCHEMBL18397024 0.83 DPP4 (0.66) MAOAMAOBDPP4TNFRSF1APTPN1
SCHEMBL1390232 0.79 MAOB (0.53) MAOAMAOBDPP4TNFRSF1AMEN1
SCHEMBL1390185 0.78 GPR183 (0.66) MAOAMAOBMEN1ALDH1A1LMNA
SCHEMBL1390537 0.74 MAOB (0.67) MAOAMAOBDPP4ABCG2ALDH1A1
SCHEMBL362851 0.74 MAOB (0.67) MAOAMAOBDPP4ABCG2ALDH1A1
SCHEMBL1390328 0.73 MAOB (0.66) MAOAMAOBABCG2MEN1ALDH1A1
SCHEMBL1390340 0.73 MAOB (0.66) MAOAMAOBMEN1ALDH1A1LMNA
SCHEMBL1390301 0.73 MAOB (0.55) MAOAMAOBTNFRSF1AABCG2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION 2025-12-23 US disclosed
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2024-07-04 US disclosed
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2022-12-15 US disclosed
CN-107922396-B Colony stimulating factor-1 receptor (CSF-1R) inhibitors 建新公司 2022-08-05 CN disclosed
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors GENZYME CORPORATION (US) 2022-03-15 US disclosed
US-20190016707-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION 2019-01-17 US disclosed
EP-3325471-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS Genzyme Corporation (US) 2018-05-30 EP disclosed
WO-2017015267-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS GENZYME CORPORATION (US) 2017-01-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11274108-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN MAOA 4351/4885MAOB 3805/4885ERN1 2717/4885
US-20240217991-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN MAOA 4351/4885MAOB 3805/4885ERN1 2717/4885
US-20220396588-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN MAOA 4351/4885MAOB 3805/4885ERN1 2717/4885
US-12503477-B2 Colony stimulating factor-1 receptor (CSF-1R) inhibitors CSF1R, CSF3R, IL1RN MAOA 4400/4885MAOB 4117/4885ERN1 2603/4885
US-20190016707-A1 COLONY STIMULATING FACTOR-1 RECEPTOR (CSF-1R) INHIBITORS CSF1R, CSF3R, IL1RN MAOA 4351/4885MAOB 3805/4885ERN1 2717/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.